TScan Therapeutics, Inc. Annual Operating Margin in % from 2020 to 2023

Taxonomy & unit
ratio: %
Description
The operating margin measures the profit a company makes on a dollar of sales after accounting for the direct costs involved in earning those revenues.
Summary
TScan Therapeutics, Inc. quarterly/annual Operating Margin history and growth rate from 2020 to 2023.
  • TScan Therapeutics, Inc. Operating Margin for the quarter ending June 30, 2024 was -915 %, a 81.8% decline year-over-year.
  • TScan Therapeutics, Inc. annual Operating Margin for 2023 was -444 %, a 9.82% increase from 2022.
  • TScan Therapeutics, Inc. annual Operating Margin for 2022 was -492 %, a 2.64% decline from 2021.
  • TScan Therapeutics, Inc. annual Operating Margin for 2021 was -480 %, a 80.2% increase from 2020.
Operating Margin, Annual (%)
Operating Margin, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date
2023 -444 +48.3 +9.82% Jan 1, 2023 Dec 31, 2023
2022 -492 -12.7 -2.64% Jan 1, 2022 Dec 31, 2022
2021 -480 +1.94K +80.2% Jan 1, 2021 Dec 31, 2021
2020 -2.42K Jan 1, 2020 Dec 31, 2020
* An asterisk sign (*) next to the value indicates that the value is likely invalid.